Citation Impact
Citing Papers
Characterization of MicroRNA Expression Levels and Their Biological Correlates in Human Cancer Cell Lines
2007 StandoutNobel
Degradation of Fibrillar Collagen in a Human Melanoma Xenograft Improves the Efficacy of an Oncolytic Herpes Simplex Virus Vector
2006 StandoutNobel
The Desmoplastic Reaction Surrounding Hepatic Colorectal Adenocarcinoma Metastases Aids Tumor Growth and Survival via αv Integrin Ligation
2008
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
2007 StandoutScience
Reversal of epigenetic aging and immunosenescent trends in humans
2019
Gene Expression Changes in an Animal Melanoma Model Correlate with Aggressiveness of Human Melanoma Metastases
2008
Untangling the ErbB signalling network
2001 Standout
Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
2001
Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer
1999
Hallmarks of Cancer: The Next Generation
2011 Standout
ErbB2 Potentiates Breast Tumor Proliferation through Modulation of p27Kip1-Cdk2 Complex Formation: Receptor Overexpression Does Not Determine Growth Dependency
2000
Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action.
2002
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
Gene expression profiling predicts clinical outcome of breast cancer
2002 StandoutNature
Role of matrix metalloproteinases (MMPs) in colorectal cancer
2003
TGF-β Released by Apoptotic T Cells Contributes to an Immunosuppressive Milieu
2001
Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors
2001
Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential
2004
Matrix metalloproteinases and the regulation of tissue remodelling
2007 Standout
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
2009 Standout
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Role of Transforming Growth Factor β in Human Disease
2000 Standout
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
2003 Standout
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Differential expression of HOX genes in neoplastic and non‐neoplastic human astrocytes
2006
Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors
2002
Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus
1999
Lung Cancer
2008 Standout
Hallmarks of aging: An expanding universe
2023 Standout
Matrix metalloproteinases in colorectal cancer: Is it worth talking about?
2003
Matrix metalloproteinase‐9,‐3 and tissue inhibitor of matrix metalloproteinase‐1 in colorectal cancer: relationship to clinicopathological variables
2006
Smad-dependent and Smad-independent pathways in TGF-β family signalling
2003 StandoutNature
The tumor microenvironment: a critical determinant of neoplastic evolution
2003
Immunity to cancer: attack and escape in T lymphocyte–tumor cell interaction
2002
Photodynamic therapy for cancer
2003 Standout
A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 ( SMAD4)
2004 Standout
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Angiogenesis in health and disease
2003 Standout
Dendritic cells and tumor immunity
2001
Epigenetics in Cancer
2008 Standout
Phase I/II Trial of Intravenous NDV-HUJ Oncolytic Virus in Recurrent Glioblastoma Multiforme
2005
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Vascular morphogenesis: tales of two syndromes
2003
Replication-selective oncolytic viruses in the treatment of cancer
2004
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage
1999 StandoutNatureNobel
Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?
2007 Standout
Molecular regulation of vessel maturation
2003 Standout
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
2000 Standout
Industrial Purification of Pharmaceutical Antibodies: Development, Operation, and Validation of Chromatography Processes
2001
TGF-?1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis
1999
Determination of the serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) in patients with either advanced small-cell lung cancer or non-small-cell lung cancer prior to treatment
2003
Endoglin Expression Is Regulated by Transcriptional Cooperation between the Hypoxia and Transforming Growth Factor-β Pathways
2002
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Soluble endoglin contributes to the pathogenesis of preeclampsia
2006 Standout
Fibroblasts in cancer
2006 Standout
Cancer epigenomics: DNA methylomes and histone-modification maps
2007 Standout
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
2007 StandoutNature
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
2012 StandoutNobel
Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer
2000
The role of matrix metalloproteinases in the pathophysiology and progression of human nervous system malignancies: a chance for the development of targeted therapeutic approaches?
2008
Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking
2014
Matrix metalloproteinases and tumor metastasis
2006 Standout
Cell Signaling by Receptor Tyrosine Kinases
2000 Standout
Generation of effective antitumor vaccines using photodynamic therapy.
2002
Convergence of Wnt, ß-Catenin, and Cadherin Pathways
2004 StandoutScience
Newcastle Disease Virus Expressing a Dendritic Cell-Targeted HIV Gag Protein Induces a Potent Gag-Specific Immune Response in Mice
2010 StandoutNobel
Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.
1997
An Adverse Role for Matrix Metalloproteinase 12 after Spinal Cord Injury in Mice
2003
The gene expression signatures of melanoma progression
2005
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Induction of Cellular Immune Responses to Simian Immunodeficiency Virus Gag by Two Recombinant Negative-Strand RNA Virus Vectors
2004
Genes and pathways downstream of telomerase in melanoma metastasis
2006 StandoutNobel
Expression profiling reveals novel pathways in the transformation of Melanocytes to Melanomas.
2004
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer
2005 StandoutNobel
Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction
2005 Standout
Effect of Inhibition of Vascular Endothelial Growth Factor Signaling on Distribution of Extravasated Antibodies in Tumors
2006
Wound Healing: A Cellular Perspective
2018 Standout
Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3
2003 Standout
Immunobiology of Dendritic Cells
2000 Standout
Metastasis Stage, Adjuvant Treatment, and Residual Tumor Are Prognostic Factors for Medulloblastoma in Children: Conclusions From the Children's Cancer Group 921 Randomized Phase III Study
1999
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Cellular and Molecular Regulation of Muscle Regeneration
2004 Standout
Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1
2007 StandoutNobel
Activities of the Matrix Metalloproteinase Stromelysin-2 (MMP-10) in Matrix Degradation and Keratinocyte Organization in Wounded Skin
2004
Cancer-induced Defective Cytotoxic T Lymphocyte Effector Function: Another Mechanism How Antigenic Tumors Escape Immune-mediated Killing
2000
Medullary Thymic Epithelium: A Mosaic of Epithelial “Self”?
1998
Recombinant Newcastle Disease Virus as a Vaccine Vector
2001
Works of B Bödey being referenced
Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas.
1997
Failure of cancer vaccines: the significant limitations of this approach to immunotherapy.
2000
Genetically Engineered Monoclonal Antibodies for Direct Anti-Neoplastic Treatment and Cancer Cell Specific Delivery of Chemotherapeutic Agents
2000
Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy
2002
MTH-68/H Oncolytic Viral Treatment in Human High-Grade Gliomas
2004
Choroid plexus tumors in childhood. Response to chemotherapy, and immunophenotypic profile using a panel of monoclonal antibodies
1992
Involution of the mammalian thymus, one of the leading regulators of aging.
1998
Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in childhood medulloblastomas/primitive neuroectodermal tumors.
2000
Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
1999
Prognostic significance of matrix metalloproteinase expression in colorectal carcinomas.
2001
Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neo-vascularization.
1998
Immunophenotypically varied cell subpopulations in primary and metastatic human melanomas. Monoclonal antibodies for diagnosis, detection of neoplastic progression and receptor directed immunotherapy.
1996
Invasion and metastasis: the expression and significance of matrix metalloproteinases in carcinomas of the lung.
2001
Immunocytochemical detection of cyclin A and cyclin D in formalin-fixed, paraffin-embedded tissues: novel, pertinent markers of cell proliferation.
1994
Immunophenotypic characterization of human primary and metastatic melanoma infiltrating leukocytes.
1997
Identification of neural crest derived cells within the cellular microenvironment of the human thymus employing a library of monoclonal antibodies raised against neuronal tissues.
1996
Matrix metalloproteinase expression in malignant melanomas: tumor-extracellular matrix interactions in invasion and metastasis.
2001
Matrix metalloproteinase expression in childhood astrocytomas.
2000
Matrix metalloproteinases in neoplasm-induced extracellular matrix remodeling in breast carcinomas.
2001
Antigen Presentation by Dendritic Cells and Their Significance in Anti-Neoplastic Immunotherapy
2006
Matrix metalloproteinase expression in childhood medulloblastomas/primitive neuroectodermal tumors.
2001
Molecular biological ontogenesis of the thymic reticulo-epithelial cell network during the organization of the cellular microenvironment.
1999
Attenuated veterinary virus vaccine for the treatment of cancer.
1993
Significant differences in the matrix metalloproteinase expression profiles of spontaneous medulloblastomas/primitive neuroectodermal tumors as compared with their xenografted, established tumor cell line derived counterparts.
2001
Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy.
1998